Substandard and falsified medical products reduce the effectiveness of treatments, causing adverse drug reactions and can accelerate antimicrobial drug resistance – threatening the lives of millions. Global investment to improve the prevention and treatment of disease is wasted if the quality of the medical products actually used by patients is poor.
Current surveillance in most of the world is extremely limited and incidents relating to poor quality medicines are often not published in peer-reviewed scientific journals. The new Medicine Quality Monitoring (MQM) Globe helps fill evidence gaps with customised summaries of national and international newspaper reports on medicines and medical products’ quality viewable on-screen in French, Spanish, Mandarin and English, and reports are available to download in three languages – English, French and Spanish. It gives early warning of new incidents, reveals the extent of the problem, how the media perceive and report cases, and may also shed light on how incidents can affect subsequent behaviours and perceptions. It has been updated to track press reports of SF medical products related to COVID-19, including key items such as masks, diagnostic tests, medicines and vaccines. There are no medicines or vaccines approved for use for COVID-19 yet. Medicines being trialled are listed here.
There are important caveats when interpreting these data. Please note in particular our takedown policy and that the information in the MQM Globe usually will not have scientific confirmation. Therefore, please interpret the information in the Globe with the greatest caution.
For more information about contributing medicine quality data to IDDO or helping us to improve the MQM Globe, please email firstname.lastname@example.org
Find out more about IDDO’s Medicine Quality work.